Icon

ADZENYS XR-ODT (nda204326)- (EQ 3.1MG BASE,EQ 6.3MG BASE,EQ 9.4MG BASE,EQ 12.5MG BASE,EQ 15.7MG BASE,EQ 18.8MG BASE)

AMPHETAMINE NEOS THERAPS
EQ 3.1MG BASE,EQ 6.3MG BASE,EQ 9.4MG BASE,EQ 12.5MG BASE,EQ 15.7MG BASE,EQ 18.8MG BASE
Yes Yes
2032-Jun-28 Expired
None None
None No
ADZENYS XR-ODT is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older.
1 0 0
Total Other Developers None
Drugs with Suitability No
EQ 3.1MG BASE ** ** Up - -
EQ 6.3MG BASE ** ** Up - -
EQ 9.4MG BASE ** ** Up - -
EQ 12.5MG BASE ** ** Up - -
EQ 15.7MG BASE ** ** Up - -
EQ 18.8MG BASE ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.